A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck. (Q37385588)
Jump to navigation
Jump to search
scientific article published on 06 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck. |
scientific article published on 06 February 2009 |
Statements
A phase I clinical study of VB4-845: weekly intratumoral administration of an anti-EpCAM recombinant fusion protein in patients with squamous cell carcinoma of the head and neck (English)
Glen C MacDonald
Michèle Rasamoelisolo
Joycelyn Entwistle
Jeannick Cizeau
Denis Bosc
Wendy Cuthbert
Mark Kowalski
Maureen Spearman
6 February 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference